Dishman Pharmaceuticals allots Equity Shares on conversion of FCCB

Dishman Pharmaceuticals & Chemicals Ltd has announced that the Board of Directors of the Company on November 17, 2006 has allotted 1,26,627 equity shares of Rs 2/- each of the Company at a premium of Rs 170/- per equity share upon exercise of option of conversion of 0.50% Foreign Currency Convertible Bonds (FCCB) of the principal amount of US$ 5,00,000 into equity shares of the Company, by the FCCB holder.

Consequently the paid-up equity share capital of the Company has increased from 6,87,94,127 equity shares of Rs 2/- each to 6,89,20,754 equity shares of Rs 2/- each.

Source : Equity Bulls

Keywords